Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Acadia, ADC, Astellas, Beigene, Crispr, Disc, Editas, Faron, Genmab, Gritstone, Immunogen, Keros, Nuvox, Roche, Ryvu, Servier, Vertex, Vor, Wugen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Edwards Lifesciences.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Annovis, Arvinas, Azafaros, Cingulate, Lianbio, Repare, Ultimovacs.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baudax, Bioinvent, Bridgebio, Coya, Durect, Emergex, Fibrogen, Fluoguide, Lixte, Ocular, Oncternal, Replimune, Rigel, Ventyx, Vera, Vistagen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Curonix, Neurometrix, Painteq.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Airway, Allovir, Anavex, Bpgbio, Cali, Defender, Galapagos, Glaukos, Harmony, Mereo, Okyo, Orsobio, Repare, Sareum, Tiziana, Ultragenyx, Vaxart, Vaxxas.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Activ Surgical, Natera, Neogenomics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko, Alterity, Aum, Beijing Luzhu, Biophytis, Brii, Caliway, Canbridge, Connect, Harbour, Revive, Structure.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Amolyt, Astrazeneca, Bellerophon, Endo, Enterin, Fogpharma, Harbour, IGM, Immuneering, Newamsterdam, Ractigen, Sirnaomics, Synlogic, Tonix, Vaxess, Vivavision, Walden.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Freestyle Partners, Gencurix, Grail.